相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Atorvastatin and fenofibrate have comparable effects on VLDL - Apolipoprotein C-III kinetics in men with the metabolic syndrome
Dick C. Chan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Kinetic studies of the metabolism of rapidly exchangeable apolipoproteins may leave investigators and readers with exchangeable results
Henry N. Ginsberg et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
Esther M. M. Ooi et al.
CLINICAL SCIENCE (2008)
Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome
Esther M. M. Ooi et al.
DIABETES CARE (2008)
Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome
D. C. Chan et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2008)
Plasma apolipoprotein C-III transport in centrally obese men: Associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism
Dick C. Chan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Factorial study of the effect of n-3 fatty acid supplementation and atorvastatin on the kinetics of HDL apolipoproteins A-I and AII in men with abdominal obesity
Dick C. Chan et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2006)
Use of Intralipid for kinetic analysis of HDL apoC-III: evidence for a homogeneous kinetic pool of apoC-III in plasma
Minh N. Nguyen et al.
JOURNAL OF LIPID RESEARCH (2006)
Effects of the PPARγ agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus
K Nagashima et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity
JS Cohn et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Foxo1 mediates insulin action on apoC-III and triglyceride metabolism
J Altomonte et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism
JS Cohn et al.
JOURNAL OF LIPID RESEARCH (2003)
Effect of sex and obesity on basal VLDL-triacylglycerol kinetics
B Mittendorfer et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2003)
New perspectives on atherogenesis role of abnormal triglyceride-rich lipoprotein metabolism
HN Ginsberg
CIRCULATION (2002)
Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia
DC Chan et al.
DIABETES (2002)
Apolipoprotein B-100 kinetics in visceral obesity: Associations with plasma apolipoprotein C-III concentration
DC Chan et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2002)
Peroxisome proliferator-activated receptor α is not rate-limiting for the lipoprotein-lowering action of fish oil
J Dallongeville et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial
FM Sacks et al.
CIRCULATION (2000)
Insulin resistance and cardiovascular disease
HN Ginsberg
JOURNAL OF CLINICAL INVESTIGATION (2000)
分享论文
